PI
-
Pretreatment PET dissemination features as biomarkers for survival outcomes in melanoma patients treated with immune-checkpoint inhibitors
Saadani, H., Aalbersberg, E. A., Kayembe, M. T., Haanen, J. B. A. G., Hoekstra, O. S., Boellaard, R. & Stokkel, M. P. M., 1 Dec 2025, In: Scientific reports. 15, 1, 21570.Research output: Contribution to journal › Article* › Academic › peer-review
-
An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients
Ferrández, M. C., Golla, S. S. V., Eertink, J. J., de Vries, B. M., Lugtenburg, P. J., Wiegers, S. E., Zwezerijnen, G. J. C., Pieplenbosch, S., Kurch, L., Hüttmann, A., Hanoun, C., Dührsen, U., de Vet, H. C. W., Hoekstra, O. S., Burggraaff, C. N., Bes, A., Heymans, M. W., Jauw, Y. W. S., Chamuleau, M. E. D. & Barrington, S. F. & 13 others, , Dec 2023, In: Scientific reports. 13, 1, 13111.Research output: Contribution to journal › Article* › Academic › peer-review
-
Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma
PETRA consortium, 22 Jun 2023, In: Blood. 141, 25, p. 3055-3064 10 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications